Who Factors $100 Million in Annual Receivables?
At $100 million a year in receivables, roughly 8 million dollars a month, factoring stops being a small ticket product and becomes institutional receivables finance. Here is who funds a book this size and how it is really priced.
Who factors $100 million in annual receivables: at this scale you are not shopping small ticket factors, you are structuring an institutional receivables purchase or asset based facility with a large bank commercial finance division, a specialty commercial finance company, a nonrecourse receivables purchase program, or a forward flow buyer. Advance rates run 85 to 90 percent, and the effective cost sits well below small ticket factoring because the funder underwrites a diversified high volume book. Pricing turns on customer credit, concentration, dilution, and days sales outstanding. PeerSense is an independent advisor that matches the book across these providers and is paid at closing only.
Who Factors $100 Million in Annual Receivables
At $100 million in annual receivables, the question is not which factoring company to call, it is how to structure an institutional receivables facility. A book this size, roughly 8 million dollars a month in billings, is funded by a small set of provider types, not by the small ticket factors that advertise to owner operators and startups.
Large bank commercial finance divisions. The asset based lending and commercial finance arms of major banks fund large receivables books as revolving facilities. They offer the tightest pricing on strong, diversified books and the deepest capacity, in exchange for full reporting and field examinations.
Specialty commercial finance companies. Nonbank finance companies that specialize in larger receivables facilities. They can move faster than a bank, tolerate more concentration or a turnaround situation, and structure around a book that does not fit a bank credit box, at a modestly wider cost.
Nonrecourse receivables purchase programs. Providers that buy the receivables outright with credit protection, often on a nonnotification basis so customers never know. Best when the company wants a large customer failure taken off its balance sheet without disturbing customer relationships.
Forward flow buyers. Institutional buyers that commit to purchasing receivables on an ongoing, programmatic basis. Relevant when the company originates a steady stream of receivables and wants committed, repeatable capital rather than a case by case facility.
The common thread is scale underwriting. At $100 million the funder prices a diversified book, not one risky invoice, which is why the effective cost is a fraction of small ticket factoring.
How a $100 Million Facility Is Really Priced
At this scale, pricing is not a flat factoring percentage. It is a base rate plus a spread, usually quoted over a short term index, plus facility fees, and the all in cost is far below the 1 to 5 percent that small carriers and agencies pay per invoice. Four levers set the number.
Customer credit quality. A book billing investment grade customers prices far tighter than one billing small private companies, because the funder is ultimately underwriting the customers that pay.
Concentration. If one or two customers dominate the book, the funder caps or discounts their eligibility, because a single large customer failure is the real risk in a big book.
Dilution. Credits, disputes, returns, and short pays that reduce collected value are measured from history and reserved against. Low dilution is worth real basis points.
Days sales outstanding. A slow paying book ties up capital longer and costs more. A book that turns quickly funds more cheaply.
A clean, diversified, low dilution $100 million book billing strong customers can price at an effective cost well under one percent of receivables, a different world from small ticket factoring.
Factoring, Asset Based Lending, or Receivables Purchase
At $100 million the structure matters more than the label, and the three common structures serve different priorities.
Traditional factoring sells the receivables to the funder, who may notify customers and collect directly. It delivers cash and outsourced collections, but notification can affect how customers view the company.
Asset based lending advances against a borrowing base of receivables and inventory as a revolving line. The company keeps collections and reports a borrowing base. It is usually the cheapest structure at scale and is nonnotification by nature, so customers are undisturbed.
Nonrecourse receivables purchase sells the receivables with credit protection, often nonnotification, so the company gets liquidity plus insulation from a large customer failure without customers ever knowing a funder is involved.
Most large, well run companies prefer a nonnotification asset based or receivables purchase structure so customer relationships stay clean, while a company that wants full credit protection and outsourced collections may choose nonrecourse purchase. The right answer depends on the company's priorities, not on a default label.
Nonrecourse and Nonnotification at Scale
At $100 million, both nonrecourse and nonnotification are common and usually desirable.
Nonrecourse means the funder absorbs a customer insolvency loss, which protects the balance sheet from a large customer failure. The protection typically covers insolvency only and carves out disputes, dilution, and billing outside an approved credit limit, so the carve out schedule is what actually determines the value.
Nonnotification means customers keep paying to a lockbox in the company's own name and never learn a funder is involved, which preserves customer relationships and market perception.
Combining the two gives a large company committed liquidity and credit protection without disturbing its customers. The trade is tighter reporting and periodic field examinations, which a company at this scale generally already supports. The detail that decides real value is the carve out schedule on the nonrecourse protection, because broad carve outs can leave less real protection than the label implies.
What PeerSense Does on a $100 Million Book
PeerSense is an independent capital advisor, not a lender and not a factor. On a receivables book this size, the structuring work is where the money is.
Run the book across multiple institutional providers at once to create real competition on rate, advance, and terms, rather than accepting one funder's first offer.
Model the eligibility rules that determine how much of the book actually funds: concentration caps, dilution reserves, ineligible aging, and cross aging. The headline advance rate means little if eligibility rules shrink the funded base.
Negotiate the terms that quietly cost the most: the reserve percentage and release cadence, minimum volume commitments, termination and early exit terms, and on nonrecourse the carve out schedule.
Structure to the company's priorities: nonnotification to protect customer relationships, nonrecourse to protect the balance sheet, or the cheapest asset based line if cost is the priority.
Because PeerSense does not fund the receivables itself and is paid at closing only, its only incentive is the tightest structure for the company, not placement with any particular funder. If you carry a receivables book near $100 million and want it structured and shopped across the institutional market, share the facts in the form below.
Structure a Large Receivables Facility
Share the size, customer mix, and current facility. PeerSense runs it across the institutional market and returns an indicative structure.
Institutional Receivables Facility ($100M book): Response within 24–48 hours. No obligation.
Questions About This Topic
Who factors $100 million in annual receivables?+
At $100 million, roughly 8 million dollars a month, the funders are large bank commercial finance divisions, specialty commercial finance companies, nonrecourse receivables purchase programs, and forward flow buyers. The structure is an institutional receivables purchase or an asset based revolver, not a per invoice small ticket program. Advance rates run 85 to 90 percent and the effective cost is far below small ticket factoring.
How much does it cost to factor a $100 million book?+
Far less than small ticket factoring. Pricing is a base rate plus a spread plus facility fees, and a clean, diversified, low dilution book billing strong customers can price at an effective cost well under one percent of receivables. Customer credit, concentration, dilution, and days sales outstanding are the four levers that set the number.
Can I factor $100 million without my customers knowing?+
Yes. At this scale nonnotification structures are common, where customers keep paying to a lockbox in your own company name and never learn a funder is involved. This is usually paired with an asset based or nonrecourse receivables purchase structure, so you get liquidity and credit protection while customer relationships stay undisturbed.
Is asset based lending cheaper than factoring at $100 million?+
Usually, yes. An asset based revolver against a borrowing base is typically the cheapest structure at scale and is nonnotification by nature, but it requires borrowing base reporting and field examinations that a company at this size generally already supports. Factoring or nonrecourse purchase wins when you want credit protection or outsourced collections. The right structure depends on your priorities.
What should I negotiate on a large receivables facility?+
The eligibility rules that shrink the funded base (concentration caps, dilution reserves, ineligible aging), the reserve percentage and how fast it releases, minimum volume commitments, termination and early exit terms, and on nonrecourse the carve out schedule that defines what the credit protection covers. These terms move the true cost more than the headline advance rate.
Editorial integrity: Published by PeerSense Capital Advisory · Written by Ed Freeman, Founder. PeerSense is a capital advisory firm, not a lender. Content is for educational purposes and does not constitute financial, legal, or tax advice. Rates and terms cited reflect approximate May 2026 market conditions and may not reflect current conditions at the time of reading. Consult a qualified financial professional for transaction-specific guidance.